Ursodeoxycholic acid improves bilirubin but not albumin in primary biliary cirrhosis: further evidence for nonefficacy

scientific article published on 24 July 2013

Ursodeoxycholic acid improves bilirubin but not albumin in primary biliary cirrhosis: further evidence for nonefficacy is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1155/2013/139763
P932PMC publication ID3741702
P698PubMed publication ID23984317
P5875ResearchGate publication ID256191025

P50authorAndrew Kenneth BurroughsQ18385218
Emmanuel TsochatzisQ28320718
James CarpenterQ52569383
P2093author name stringJiannis Vlachogiannakos
Cristina Rigamonti
Maurille Feudjo
P2860cites workUrsodeoxycholic acid for primary biliary cirrhosisQ24241945
Multilevel modelling of medical dataQ28206769
A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study GroupQ28243457
Ursodeoxycholic acid for primary biliary cirrhosis.Q32064450
Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysisQ33745849
Ursodeoxycholic acid: Mechanism of action and novel clinical applicationsQ37012207
Survival following the development of ascites and/or peripheral oedema in primary biliary cirrhosis: a staged prognostic modelQ38937793
Prediction of short-term survival with an application in primary biliary cirrhosisQ39085766
Surrogate endpoints in clinical trials: definition and operational criteriaQ41310696
Ursodeoxycholic acid treatment in patients with primary biliary cirrhosis. A Swedish multicentre, double-blind, randomized controlled studyQ42551010
Ursodeoxycholic acid and primary biliary cirrhosis: EASL and AASLD guidelinesQ43253298
Ursodeoxycholic acid for primary biliary cirrhosis: final results of a 12-year, prospective, randomized, controlled trialQ44110703
Ursodeoxycholic acid and histological progression in primary biliary cirrhosisQ44671802
Predicting the advent of ascites and other complications in primary biliary cirrhosis: a staged model approach.Q44706114
Prognosis in primary biliary cirrhosis: model for decision makingQ46316848
The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosisQ49110706
A randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosisQ51586165
Criteria for the validation of surrogate endpoints in randomized experiments.Q52230235
Statistical validation of intermediate endpoints for chronic diseasesQ68115549
Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trialQ69357047
A two year controlled trial examining the effectiveness of ursodeoxycholic acid in primary biliary cirrhosisQ71995039
A placebo-controlled trial of primary biliary cirrhosis treatment with colchicine and ursodeoxycholic acidQ72189521
Ursodeoxycholic acid in the treatment of primary biliary cirrhosisQ72401649
Updating prognosis in primary biliary cirrhosis using a time-dependent Cox regression model. PBC1 and PBC2 trial groupsQ72638625
Ursodeoxycholic acid for symptomatic primary biliary cirrhosis. Preliminary analysis of a double-blind multicenter trial. Italian Multicenter Group for the Study of UDCA in PBCQ72789964
Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: results of a double-blind controlled multicentric trial. UDCA-Cooperative Group from the Spanish Association for the Study of the LiverQ73715566
Primary biliary cirrhosisQ81246142
P275copyright licenseCreative Commons Attribution 3.0 UnportedQ14947546
P6216copyright statuscopyrightedQ50423863
P407language of work or nameEnglishQ1860
P921main subjectprimary biliary cholangitisQ1072420
P304page(s)139763
P577publication date2013-07-24
P1433published inBioMed Research InternationalQ17509958
P1476titleUrsodeoxycholic acid improves bilirubin but not albumin in primary biliary cirrhosis: further evidence for nonefficacy
P478volume2013

Reverse relations

cites work (P2860)
Q36193470Case-control study on prednisolone combined with ursodeoxycholic acid and azathioprine in pure primary biliary cirrhosis with high levels of immunoglobulin G and transaminases: efficacy and safety analysis
Q38616218Defibrotide for children and adults with hepatic veno-occlusive disease post hematopoietic cell transplantation
Q57301971Defibrotide for the treatment of hepatic veno-occlusive disease/sinusoidal obstruction syndrome with multiorgan failure
Q51300509Protective effect of ursodeoxycholic acid, resveratrol, and N-acetylcysteine on nonalcoholic fatty liver disease in rats.

Search more.